US pharma giant buys Germany's Celesio in $8-bn deal

US pharmaceutical distributor McKesson on Thursday announced the purchase of German rival Celesio in a deal valued at more than $8 billion.

The combined company "will be one of the largest pharmaceutical wholesalers and providers of logistics and services in the worldwide," the German firm said in a statement.

The total transaction, including McKesson's takeover of Celesio's outstanding debt is valued at approximately $8.3 billion (6.3 billion euros, the statement added.

Both firms will keep their own separate brands.

The combined firm is expected to have annual revenue of more than $150 billion, employing some 81,500 people in 20 countries worldwide.

Earlier in the month, shares in McKesson rose sharply after the Wall Street Journal reported news of the buy-out.

© 2013 AFP

Citation: US pharma giant buys Germany's Celesio in $8-bn deal (2013, October 24) retrieved 29 March 2024 from https://medicalxpress.com/news/2013-10-pharma-giant-germany-celesio-bn.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Israeli generic drug giant Teva to buy Cephalon

 shares

Feedback to editors